Evidence map›Paper›PMID 37410978›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Debating Sentinel Lymph Node Biopsy for Melanoma in the Modern Adjuvant Era.

Xiaoran Zhang, Laura Ferris, Mark B Faries, Jason J Luke

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma.American journal of clinical dermatology · 2024
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaoran ZhangUPMC Hillman Cancer Center, Pittsburgh, PA.ORCID 0000-0002-4654-6055
Laura FerrisUPMC Hillman Cancer Center, Pittsburgh, PA.ORCID 0000-0002-0598-5182
Mark B FariesDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.ORCID 0000-0003-1752-7282
Jason J LukeUPMC Hillman Cancer Center, Pittsburgh, PA.ORCID 0000-0002-1182-4908

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Project 5: Microenvironment manipulation using anti-angiogenics to improve immunotherapy in melanomaP50CA254865 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIRKWOOD, JOHN MUNN, ZAROUR, HASSANE M · 2021 to 2025
$10.4M
NCI ET-CTN with Phase i Emphasis at UPCIUM1CA186690 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD, Farshid Dayyani · 2014 to 2026
$9.1M
Immune Exclusion in Cancer ImmunotherapyR01DE031729 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Riyue Bao, Dan Paul Zandberg · 2022 to 2026
$3.0M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA254865NCI NIH HHS UM1 CA186690NIDCR NIH HHS R01 DE031729
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MelanomaSkin NeoplasmsHumansLymph Node ExcisionLymph NodesSentinel Lymph Node Biopsy

Identifiers

PMID37410978
PMCPMC10852382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.